Meeting
2014 ASCO Quality Care Symposium
Assessing the impact of a targeted electronic medical record intervention on growth factor usage in cancer patients.
Authors
Jordan Bernens
West Virginia University, School of Medicine, Morgantown, WV
Jordan Bernens, Kara Hartman, Brendan F. Curley, Sijin Wen, Jame Abraham, Michael David Newton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Quality Measurement
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 262)
DOI
10.1200/jco.2014.32.30_suppl.262
Abstract #
262
Poster Bd #
F3
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).
First Author: Jaime Shaw
Poster
2013 ASCO Annual Meeting
How oncologists adhere to evidence-based G-CSF-guidelines to prevent febrile neutropenia: A sample survey in hospitals and practices in Germany.
First Author: Hartmut Link
Poster
2023 ASCO Genitourinary Cancers Symposium
A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future.
First Author: Nely Mercy Diaz Mejia
Poster
2011 ASCO Annual Meeting
Incidence of febrile neutropenia with docetaxel plus cyclophosphamide in a university-based breast oncology clinic.
First Author: A. Soni